Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
- Published In:
- Diabetologia, 67(7), 1206-1222 (2024)
- Authors:
- Karagiannis, Thomas, Malandris, Konstantinos, Avgerinos, Ioannis, Stamati, Athina, Kakotrichi, Panagiota, Liakos, Aris, Vasilakou, Despoina, Kakaletsis, Nikolaos, Tsapas, Apostolos, Bekiari, Eleni
- Database ID:
- RPEP-08519
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08519APA
Karagiannis, Thomas; Malandris, Konstantinos; Avgerinos, Ioannis; Stamati, Athina; Kakotrichi, Panagiota; Liakos, Aris; Vasilakou, Despoina; Kakaletsis, Nikolaos; Tsapas, Apostolos; Bekiari, Eleni. (2024). Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.. Diabetologia, 67(7), 1206-1222. https://doi.org/10.1007/s00125-024-06144-1
MLA
Karagiannis, Thomas, et al. "Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.." Diabetologia, 2024. https://doi.org/10.1007/s00125-024-06144-1
RethinkPeptides
RethinkPeptides Research Database. "Subcutaneously administered tirzepatide vs semaglutide for a..." RPEP-08519. Retrieved from https://rethinkpeptides.com/research/karagiannis-2024-subcutaneously-administered-tirzepatide-vs
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.